p53-话题@MedSci

#p53#

135篇内容 | 4305人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1372395, encodeId=528413e239518, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Gastroenterology：TP53是巴雷特食管患者高级别进展的重要预测因素, objectType=article, longId=134157, objectId=f50813415ea6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f50813415ea6, replyNumber=0, likeNumber=56, createdTime=2018-04-05, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f50813415ea6, moduleTitle=Gastroenterology：TP53是巴雷特食管患者高级别进展的重要预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f50813415ea6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372394, encodeId=91c913e2394d0, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感, objectType=article, longId=133937, objectId=40e013393ec7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e013393ec7, replyNumber=0, likeNumber=60, createdTime=2018-04-02, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e013393ec7, moduleTitle=P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e013393ec7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372393, encodeId=b5df13e2393d7, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Cell Rep：防癌卫士p53也会帮助癌细胞避免发生铁死亡, objectType=article, longId=127645, objectId=82a712e645e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82a712e645e9, replyNumber=0, likeNumber=85, createdTime=2018-01-26, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82a712e645e9, moduleTitle=Cell Rep：防癌卫士p53也会帮助癌细胞避免发生铁死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82a712e645e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372392, encodeId=fab213e2392b3, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Prostate Cancer P D：原发性肿瘤中p53状态可以预测阿比特龙和恩杂鲁胺在去势难治性前列腺癌中的疗效, objectType=article, longId=126811, objectId=f80c126811b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f80c126811b1, replyNumber=0, likeNumber=78, createdTime=2018-01-19, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f80c126811b1, moduleTitle=Prostate Cancer P D：原发性肿瘤中p53状态可以预测阿比特龙和恩杂鲁胺在去势难治性前列腺癌中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f80c126811b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372391, encodeId=ddd113e239163, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=JCO：TP53胚系突变与儿童急性淋巴细胞白血病的易感性和预后的关系, objectType=article, longId=126478, objectId=4bd21264e81e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bd21264e81e, replyNumber=0, likeNumber=67, createdTime=2018-01-15, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bd21264e81e, moduleTitle=JCO：TP53胚系突变与儿童急性淋巴细胞白血病的易感性和预后的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bd21264e81e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372390, encodeId=fb4313e239080, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=BIOCH PHARM：人参皂甙Rh4通过激活结直肠癌细胞中的ROS / JNK / p53途径诱导细胞凋亡和自噬性细胞死亡, objectType=article, longId=124942, objectId=ca74124942ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca74124942ad, replyNumber=0, likeNumber=70, createdTime=2017-12-30, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca74124942ad, moduleTitle=BIOCH PHARM：人参皂甙Rh4通过激活结直肠癌细胞中的ROS / JNK / p53途径诱导细胞凋亡和自噬性细胞死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca74124942ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372389, encodeId=788813e238954, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nat Commun：研究提出利用p53成功抗击癌症的新方法！, objectType=article, longId=123464, objectId=7d99123464c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d99123464c3, replyNumber=0, likeNumber=57, createdTime=2017-12-16, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d99123464c3, moduleTitle=Nat Commun：研究提出利用p53成功抗击癌症的新方法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d99123464c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372388, encodeId=2f0e13e238845, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Blood：TP53高表达，可用于预测MCL患者预后不良。, objectType=article, longId=122177, objectId=37191221e780, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37191221e780, replyNumber=0, likeNumber=69, createdTime=2017-12-05, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37191221e780, moduleTitle=Blood：TP53高表达，可用于预测MCL患者预后不良。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37191221e780)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372387, encodeId=9f2e13e238761, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Int J Mol Med：低剂量放射可以通过ATM/p21信号通路抑制人类p53null类型前列腺癌细胞的增殖, objectType=article, longId=120868, objectId=4b3512086845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b3512086845, replyNumber=0, likeNumber=54, createdTime=2017-11-22, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b3512086845, moduleTitle=Int J Mol Med：低剂量放射可以通过ATM/p21信号通路抑制人类p53null类型前列腺癌细胞的增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b3512086845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372386, encodeId=ed1613e238683, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=J Periodontol：信号调节蛋白激酶/蛋白激酶B-p53-BH3–结构域凋亡诱导蛋白通路调节成骨细胞牙龈素诱导的细胞凋亡, objectType=article, longId=119738, objectId=5e0a119e387d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e0a119e387d, replyNumber=0, likeNumber=56, createdTime=2017-11-13, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e0a119e387d, moduleTitle=J Periodontol：信号调节蛋白激酶/蛋白激酶B-p53-BH3–结构域凋亡诱导蛋白通路调节成骨细胞牙龈素诱导的细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e0a119e387d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372385, encodeId=d7c613e23851d, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Sci Adv：通过shRNA文库鉴定XBP1-u是MDM2/p53轴的新型调节剂, objectType=article, longId=118570, objectId=bde01185e0d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bde01185e0d5, replyNumber=0, likeNumber=80, createdTime=2017-11-04, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bde01185e0d5, moduleTitle=Sci Adv：通过shRNA文库鉴定XBP1-u是MDM2/p53轴的新型调节剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bde01185e0d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372384, encodeId=d5af13e238467, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nature：研究靶向“无药可医”的癌症目标，激活P53治癌症值得期待！, objectType=article, longId=117242, objectId=c4b411e24281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4b411e24281, replyNumber=0, likeNumber=73, createdTime=2017-10-25, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4b411e24281, moduleTitle=Nature：研究靶向“无药可医”的癌症目标，激活P53治癌症值得期待！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4b411e24281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372383, encodeId=64f813e2383de, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Sci Adv：我国科学家发现肿瘤抑制因子p53调控机制, objectType=article, longId=116931, objectId=ac971169310f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac971169310f, replyNumber=0, likeNumber=77, createdTime=2017-10-22, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac971169310f, moduleTitle=Sci Adv：我国科学家发现肿瘤抑制因子p53调控机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac971169310f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372382, encodeId=070113e23828f, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Sci Rep：lncRNA-p53调控网络的基因多态性或可改善鼻咽癌患者的预后, objectType=article, longId=112494, objectId=ef83112494fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef83112494fc, replyNumber=0, likeNumber=62, createdTime=2017-09-11, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef83112494fc, moduleTitle=Sci Rep：lncRNA-p53调控网络的基因多态性或可改善鼻咽癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef83112494fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372381, encodeId=eb6a13e23812f, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Oncotarget：PARP1表达和TP53状态是区分胶质母细胞瘤亚型可靠标记物, objectType=article, longId=111113, objectId=6a2711111356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a2711111356, replyNumber=0, likeNumber=56, createdTime=2017-08-30, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a2711111356, moduleTitle=Oncotarget：PARP1表达和TP53状态是区分胶质母细胞瘤亚型可靠标记物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a2711111356)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372380, encodeId=367d13e238051, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Blood：携带TP53突变的套细胞淋巴瘤患者对现有疗法没有反应。, objectType=article, longId=109240, objectId=9dcd109240f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dcd109240f3, replyNumber=0, likeNumber=110, createdTime=2017-08-20, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dcd109240f3, moduleTitle=Blood：携带TP53突变的套细胞淋巴瘤患者对现有疗法没有反应。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dcd109240f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372379, encodeId=720413e2379b2, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Oncotarget：小分子CP有治疗p53异常的多发性骨髓瘤潜力, objectType=article, longId=108019, objectId=716d10801958, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=716d10801958, replyNumber=0, likeNumber=58, createdTime=2017-08-09, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=716d10801958, moduleTitle=Oncotarget：小分子CP有治疗p53异常的多发性骨髓瘤潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=716d10801958)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372378, encodeId=8f8a13e237817, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Oncogene：在前列腺癌中，雄激素可诱导G3BP2和SUBO调控的p53核输出, objectType=article, longId=105831, objectId=875b105831ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875b105831ea, replyNumber=0, likeNumber=65, createdTime=2017-07-19, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875b105831ea, moduleTitle=Oncogene：在前列腺癌中，雄激素可诱导G3BP2和SUBO调控的p53核输出, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=875b105831ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372377, encodeId=cc4513e237759, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应, objectType=article, longId=104354, objectId=cb2b10435459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2b10435459, replyNumber=0, likeNumber=66, createdTime=2017-07-04, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2b10435459, moduleTitle=CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2b10435459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372376, encodeId=1ccd13e237629, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Blood：髓系P53可调节巨噬细胞极化与深静脉血栓分解, objectType=article, longId=102200, objectId=d2b010220055, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2b010220055, replyNumber=0, likeNumber=69, createdTime=2017-06-18, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2b010220055, moduleTitle=Blood：髓系P53可调节巨噬细胞极化与深静脉血栓分解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2b010220055)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

p53

2020-05-29

zhishijing (审核中...)

前往app查看评论内容

#p53#

Gastroenterology：TP53是巴雷特食管患者高级别进展的重要预测因素

2018-04-05

zhishijing (审核中...)

前往app查看评论内容

#p53#

P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感

2018-04-02

zhishijing (审核中...)

前往app查看评论内容

#p53#

Cell Rep：防癌卫士p53也会帮助癌细胞避免发生铁死亡

2018-01-26

zhishijing (审核中...)

前往app查看评论内容

#p53#

Prostate Cancer P D：原发性肿瘤中p53状态可以预测阿比特龙和恩杂鲁胺在去势难治性前列腺癌中的疗效

2018-01-19

zhishijing (审核中...)

前往app查看评论内容

#p53#

JCO：TP53胚系突变与儿童急性淋巴细胞白血病的易感性和预后的关系

2018-01-15

zhishijing (审核中...)

前往app查看评论内容

#p53#

BIOCH PHARM：人参皂甙Rh4通过激活结直肠癌细胞中的ROS / JNK / p53途径诱导细胞凋亡和自噬性细胞死亡

2017-12-30

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nat Commun：研究提出利用p53成功抗击癌症的新方法！

2017-12-16

zhishijing (审核中...)

前往app查看评论内容

#p53#

Blood：TP53高表达，可用于预测MCL患者预后不良。

2017-12-05

zhishijing (审核中...)

前往app查看评论内容

#p53#

Int J Mol Med：低剂量放射可以通过ATM/p21信号通路抑制人类p53null类型前列腺癌细胞的增殖

2017-11-22

zhishijing (审核中...)

前往app查看评论内容

#p53#

J Periodontol：信号调节蛋白激酶/蛋白激酶B-p53-BH3–结构域凋亡诱导蛋白通路调节成骨细胞牙龈素诱导的细胞凋亡

2017-11-13

zhishijing (审核中...)

前往app查看评论内容

#p53#

Sci Adv：通过shRNA文库鉴定XBP1-u是MDM2/p53轴的新型调节剂

2017-11-04

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nature：研究靶向“无药可医”的癌症目标，激活P53治癌症值得期待！

2017-10-25

zhishijing (审核中...)

前往app查看评论内容

#p53#

Sci Adv：我国科学家发现肿瘤抑制因子p53调控机制

2017-10-22

zhishijing (审核中...)

前往app查看评论内容

#p53#

Sci Rep：lncRNA-p53调控网络的基因多态性或可改善鼻咽癌患者的预后

2017-09-11

zhishijing (审核中...)

前往app查看评论内容

#p53#

Oncotarget：PARP1表达和TP53状态是区分胶质母细胞瘤亚型可靠标记物

2017-08-30

zhishijing (审核中...)

前往app查看评论内容

#p53#

Blood：携带TP53突变的套细胞淋巴瘤患者对现有疗法没有反应。

2017-08-20

zhishijing (审核中...)

前往app查看评论内容

#p53#

Oncotarget：小分子CP有治疗p53异常的多发性骨髓瘤潜力

2017-08-09

zhishijing (审核中...)

前往app查看评论内容

#p53#

Oncogene：在前列腺癌中，雄激素可诱导G3BP2和SUBO调控的p53核输出

2017-07-19

zhishijing (审核中...)

前往app查看评论内容

#p53#

CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应

2017-07-04

zhishijing (审核中...)

前往app查看评论内容

#p53#

Blood：髓系P53可调节巨噬细胞极化与深静脉血栓分解

2017-06-18

科室
- - 订阅+
  - 更多科室
工具
服务